• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR Back to Search Results
Model Number OP-05W
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Pulmonary Edema (2020); No Known Impact Or Consequence To Patient (2692)
Event Date 04/05/2019
Event Type  Death  
Manufacturer Narrative
This incident occurred in (b)(6) and is reported to fda according to the requirement.Op-05w is identical model to op-05w(a) marketed in us.The product of this event was not returned to the manufacturer and could not be analyzed.The lot number of the product was not reported and we could not review the manufacturing and quality control records.According to the physician's comment, her treatments of dfpp from the first one to the fourth one were performed without any problem.After several hours from the end of the fifth treatment of dfpp, she developed acute pulmonary oedema, as the result of elevation of her blood vessel permeability caused by the allergic reaction etc.The cause of this event was known, either by the displacement liquid or by dfpp.The physician considered that this event was not caused by op because this event occurred several hours after the end of the dfpp treatment, but that the causal relationship between this event and op was not denied as direct cause of this event was not identified.We considered that this event was serious adverse event because the outcome was death.The causal relationship between the event and op was not denied, because the patient experienced the acute pulmonary oedema after her dfpp treatment.The caution as to this event is not written in the package insert of op, but this case is the first adverse event whose causal relationship was not denied for us to receive, we will continue to monitor the occurrence of these kinds of events.
 
Event Description
This case occurred in the facility of (b)(6).On (b)(6) 2019: this patient was started with the fifth treatment of double filtration plasma exchange(dfpp) of op-05w, which was used as plasma separator and was similar product of op-05w(a) sold in us, and cascadeflo ec-20w, which fractionate plasma into large and small molecular weight components.After three hours from the beginning of the treatment, her treatment finished, and she returned her room.After four hours from the end of the treatment, she was found fallen down in the rest room.After four hours and half from the end of the treatment, her hemoglobin(hb) value increased to 17.8 g/dl.After seven hours from the end of the treatment, the result of the computed tomography scan test showed suspected pneumonedema.After seven hours and forty five minutes from the end of the treatment, her hb value increased to 20.4 g/dl.After eight hours from the end of the treatment, her aspiration was supported with the noninvasive positive pressure ventilation(nppv), but did not improve, so she was given the treatment with cannulation.She was diagnosed as acute respiratory failure, acute heart failure, and acute pulmonary oedema, and was transferred to the intensive-care unit.On (b)(6) 2019: after 13 hours from the end of the treatment, the patient experienced acidosis, and was given the treatment with continuous renal replacement therapy (crrt).After 15 hours from the end of the treatment, the patient has died.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLASMAFLO OP
Type of Device
PLASMA SEPARATOR
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-1-2 yurakucho
chiyoda-ku
tokyo 100-0 006
JA  100-0006
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP.
oita works
2111-2 oaza sato
oita-shi, oita 870-0 396
JA   870-0396
Manufacturer Contact
akitake yamashita
1-1-2 yurakucho, chiyoda-ku
tokyo 100-0-006
JA   100-0006
MDR Report Key8602378
MDR Text Key144801673
Report Number8010002-2019-00070
Device Sequence Number1
Product Code MDP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P820033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 04/15/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/12/2019
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Model NumberOP-05W
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/15/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age74 YR
-
-